Next Article in Journal
Inside the Hospitalization Voyage of Schizophrenia Care: A Single-Center Journey
Previous Article in Journal
The Clinical Utility of Serum Alpha-1-Acid Glycoprotein in Reflecting the Cross-Sectional Activity of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A Single-Centre Retrospective Study
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Comment

Comment on Utsumi et al. Differences in Pathophysiology and Treatment Efficacy Based on Heterogeneous Out-of-Hospital Cardiac Arrest. Medicina 2024, 60, 510

by
Raghuraman M. Sethuraman
1,*,
Buddhan Rajarathinam
2 and
Pranjali Kurhekar
1
1
Department of Anesthesiology, Sree Balaji Medical College & Hospital, BIHER, Chennai 600044, India
2
Department of Critical Care, Kauvery Hospital, Vadapalani, Chennai 600026, India
*
Author to whom correspondence should be addressed.
Medicina 2024, 60(8), 1213; https://doi.org/10.3390/medicina60081213
Submission received: 17 May 2024 / Revised: 28 June 2024 / Accepted: 15 July 2024 / Published: 26 July 2024
(This article belongs to the Section Cardiology)

Abstract

:
We read with great interest the review article on pathophysiology and treatment based on different out-of-hospital cardiac arrest (OHCA) patients. We wish to present our comments on the threshold values for neuron-specific enolase (NSE) based on the initial rhythm and the misquoting of a few references in that article.

We read with great interest the review article on pathophysiology and treatment based on different out-of-hospital cardiac arrest (OHCA) patients. We compliment Utsumi et al. [1] for this comprehensive review and wish to provide our comments.
While discussing the role of serum neuron-specific enolase (NSE) for the neurological outcomes in shockable and non-shockable OHCA patients, Utsumi et al. state that the cut-off value of NSE with a false positive rate ratio of <1% is also different for the non-shockable, shockable groups “(69.3 [sensitivity 42.1%] vs. 102.7 [sensitivity 76%] ng/mL, respectively)” [1]. This was stated based on a recently published article by Kim et al. [2]. However, in our view, Kim et al. [2] misinterpreted their results. As the median value of the shockable group was significantly lower than the non-shockable group (25.9 vs. 104.6) [2], it is not possible to have a higher cut-off for the shockable group. Hence, the correct NSE cut-off value should be 102.7 ng/mL for the non-shockable rhythm and 69.3 ng/mL for the shockable rhythm, and not vice versa. Furthermore, the sensitive values were also interchanged. It should have been 76% for the non-shockable and 42.1% for the shockable group. In addition, there were also some inconsistencies while reporting the results (sensitivity, false-positive ratio) in that study. Importantly, this is not a simple typographical error made by Kim et al. [2] as their discussion and conclusions are also based on this misinterpretation and thus could potentially mislead the researchers as is the case with Utsumi et al. [1].
Additionally, Utsumi et al. [1] misquoted the referenced article by Kim et al. [2] (cited as reference # 24 in the review article of Utsumi et al. [1]) while discussing the role of adrenaline for treatment during resuscitation. Kim et al. analyzed the impact of initial rhythm on the prognostic values of serum NSE [2], as mentioned earlier, and did not study the effects of adrenaline.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Utsumi, S.; Nishikimi, M.; Ohshimo, S.; Shime, N. Differences in Pathophysiology and Treatment Efficacy Based on Heterogeneous Out-of-Hospital Cardiac Arrest. Medicina 2024, 60, 510. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
  2. Kim, Y.J.; Kim, Y.H.; Youn, C.S.; Cho, I.S.; Kim, S.J.; Wee, J.H.; Park, Y.S.; Oh, J.S.; Lee, B.K.; Kim, W.Y. Different neuroprognostication thresholds of neuron-specific enolase in shockable and non-shockable out-of-hospital cardiac arrest: A prospective multicenter observational study in Korea (the KORHN-PRO registry). Crit. Care 2023, 27, 313. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Sethuraman, R.M.; Rajarathinam, B.; Kurhekar, P. Comment on Utsumi et al. Differences in Pathophysiology and Treatment Efficacy Based on Heterogeneous Out-of-Hospital Cardiac Arrest. Medicina 2024, 60, 510. Medicina 2024, 60, 1213. https://doi.org/10.3390/medicina60081213

AMA Style

Sethuraman RM, Rajarathinam B, Kurhekar P. Comment on Utsumi et al. Differences in Pathophysiology and Treatment Efficacy Based on Heterogeneous Out-of-Hospital Cardiac Arrest. Medicina 2024, 60, 510. Medicina. 2024; 60(8):1213. https://doi.org/10.3390/medicina60081213

Chicago/Turabian Style

Sethuraman, Raghuraman M., Buddhan Rajarathinam, and Pranjali Kurhekar. 2024. "Comment on Utsumi et al. Differences in Pathophysiology and Treatment Efficacy Based on Heterogeneous Out-of-Hospital Cardiac Arrest. Medicina 2024, 60, 510" Medicina 60, no. 8: 1213. https://doi.org/10.3390/medicina60081213

Article Metrics

Back to TopTop